Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy.
about
Optimizing the use of thiopurines in inflammatory bowel diseaseIdiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment OptionsSuccessful Treatment of Small Intestinal Bleeding in a Crohn's Patient with Noncirrhotic Portal Hypertension by Transjugular Portosystemic Shunt Placement and Infliximab Treatment.Use of thiopurines in inflammatory bowel disease: Safety issues.Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease.Thioguanine in inflammatory bowel disease: Long-term efficacy and safetyDrug-induced liver injury in inflammatory bowel disease: 1-year prospective observational studyChallenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesisAdverse events in IBD: to stop or continue immune suppressant and biologic treatmentThe role of thiopurine metabolite monitoring in inflammatory bowel disease.Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease.Optimizing pharmacologic management of inflammatory bowel disease.Synthetic pharmacotherapy for lupus nephritis.Nodular Regenerative Hyperplasia of the Liver in Patients with IBD Treated with Allopurinol-Thiopurine Combination Therapy.High prevalence of cholestasis, with increased conjugated bile acids in inflammatory bowel diseases patients.Nodular regenerative hyperplasia in inflammatory bowel disease patients with allopurinol-thiopurine cotherapySystemic lupus erythematosus complicated by noncirrhotic portal hypertension: A case report and review of literature
P2860
Q28082687-80B77CFE-D12F-407C-B87C-47F440CBE923Q28084761-452476BF-4F83-4640-8753-BAA2F2962D84Q33437400-F89B61C8-0007-452A-917F-76C1FF575A05Q33621267-AFC08D88-77C8-4A2F-A56E-CB0C655AE90CQ33654733-1B00ACB1-A10E-4442-93A7-8F3A1AAC38C7Q33731976-223A9CD3-7E35-4828-A178-25E072CA35F4Q33805921-0EC1F97B-F166-4CB3-84F0-5FBCDF022DC0Q33845138-9ADB2220-4DC3-4D21-B27D-FD8F36CA937CQ34073191-E2EBD357-AE0C-4EC8-8F1F-4FB613786475Q38200692-20CDE377-1114-433E-8BC9-06DB534801F3Q38563075-6D90AFE7-0A23-4BF5-A884-0C02429256B0Q38687407-6BD9B924-5696-4B90-8DB2-E8D1DB352310Q39064602-3D3050F0-FCB9-4CC9-ACC3-CE427220A639Q50217361-956441B3-889B-4DD4-9EC5-A58EA2846AF7Q55031134-67272996-A129-43CA-8A33-3DC056DE7E2EQ58763029-63221567-FCBD-4D7D-971F-BD12C19E996DQ59133428-B9E42F5B-DAC2-4612-844E-7BF869C90407
P2860
Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Review article: the associatio ...... isease and thiopurine therapy.
@ast
Review article: the associatio ...... isease and thiopurine therapy.
@en
type
label
Review article: the associatio ...... isease and thiopurine therapy.
@ast
Review article: the associatio ...... isease and thiopurine therapy.
@en
prefLabel
Review article: the associatio ...... isease and thiopurine therapy.
@ast
Review article: the associatio ...... isease and thiopurine therapy.
@en
P2860
P356
P1476
Review article: the associatio ...... isease and thiopurine therapy.
@en
P2093
C O Musumba
P2860
P304
P356
10.1111/APT.12490
P407
P577
2013-09-16T00:00:00Z